Diabetes Care in The Netherlands: - Novo Nordisk

Booz & Company is a global management and strategy consulting firm, helpingthe world’s top businesses, governments and organizations. With morethan 3,300 people in 60 offices around the world, Booz & Company bringsforesight and knowledge, deep functional expertise, and a practicalapproach to building capabilities and delivering real impact. Booz & Companyis ranked the #1 management consultancy firm by clients in the annualDutch Incompany 100 Survey of 2011.Former minister of Healthcare, Ab Klink, works at Booz & Company inAmsterdam. Ab Klink combines this job with his position as Professor ofHealthcare, Labour and Political Direction at the Vrije Universiteit in Amsterdam.His extensive knowledge and insight in the healthcare sector contribute tohigh quality strategic advice on urgent issues in Dutch healthcare.www.booz.comAs a world leader in diabetes care Novo Nordisk’s aspiration is to defeatdiabetes by finding better methods of diabetes prevention, detection andtreatment. This includes initiatives contributing to activities to reduce thegrowth of diabetes related costs for society. The Changing Diabetes programhas been developed to support these initiatives. The program entails variousnational and international initiatives, focussing on communication with andproviding information to people with diabetes, their families, friends,educators, politicians, health care professionals, healthcare insurancecompanies, and other stakeholders. With the Changing Diabetes programNovo Nordisk wants to change and improve the way diabetes is treated andmanaged by society.Novo Nordisk is a global pharmaceutical company with almost 90 years ofexperience in the field of diabetes care. The company offers innovativemedicines, advanced administration systems as well as services to optimisethe treatment of people with diabetes. Furthermore, Novo Nordisk sets thestandard in the areas of haemostasis, growth hormone therapy andhormone substitution therapy.Novo Nordisk has more than 30.000 employees in 76 countries, bringingproducts to patients in 179 countries. Novo Nordisk B.V. holds the thirdposition in the 2011 Great Place to Work listing and is 16 th on the Europeanlist of the 25 Best Multinational Workplaces in Europe 2011. This makesNovo Nordisk one of the best employers in The Netherlands in 2011.www.novonordisk.nlwww.changingdiabetes.nl9 789081 787741